P
|
Patients with extra-abdominal desmoid fibromatosis |
I
|
Nonoperative treatment using COX2 inhibitors |
C
|
Watchful waiting |
Clinical context
|
Since desmoid fibromatosis shrink spontaneously in some cases, careful follow-up by “wait and see” may be performed. Verify whether COX2 inhibitors are more useful for extra-abdominal desmoid fibromatosis than “wait and see” as a drug treatment. |
Outcome
|
Response rate
|
Summary of indirectness
|
All 4 studies do not have a watchful waiting group |
Summary of bias risk
|
All are retrospective studies and have a high risk of bias |
Summary of inconsistencies
|
Subjects include first-onset and recurrent cases, and are inconsistent |
Comment
|
All are retrospective and do not include the watchful waiting group, so the level of evidence is low. |